Cowen And Company, LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Cowen And Company, LLC

  • $3.88 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$77.92 - $102.4 $545,440 - $716,800
-7,000 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$92.19 - $115.71 $645,330 - $809,970
7,000 New
7,000 $28,000
Q1 2021

May 04, 2021
SELL
$106.9 - $167.73 $1.33 Million - $2.08 Million
-12,400 Closed
0 $0
Q4 2020

Feb 08, 2021
BUY
$84.4 - $177.39 $1.05 Million - $2.2 Million
12,400 New
12,400 $80,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.14B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Cowen And Company, LLC Portfolio

Follow Cowen And Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen And Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email